Bioceres Crop Solutions Corp. · NASDAQ:BIOX
Bioceres Crop Solutions — Q3 2026 Earnings Presentation
16 slides from Bioceres Crop Solutions's earnings presentation, May 12, 2026
Slide 1: Fiscal Third Quarter 2026
Fiscal Third Quarter 2026 May 2026
Slide 2: Disclaimer
BIOCERES CROP SOLUTIONS Disclaimer Industry and Market Data Unless otherwise noted, the forecasted industry and market data contained in the assumptions for the projections are based upon the Company’s management estimates The Company believes that these non-IFRS measures of financial results provid
Slide 3: Key Business & Financial Highlights
BIOCERES CROP SOLUTIONS Key Business & Financial Highlights ● Total revenues were $39.4 million in 3Q26, ● Net loss was $10.0 million and Adjusted a 23% year-over-year decline, reflecting softer EBITDA1 was $(0.6) million, primarily demand and competitive pressures in Crop reflecting lower gross pro
Slide 4: Litigation Update
BIOCERES CROP SOLUTIONS Litigation Update Jasper Lake Ventures One LLC, et al. v. Bioceres Crop Solutions Corp., et al. (Index No. 659704/2025) Plaintiffs allege defaults under NPAs (August 2022) and amendments thereto (June 2025) Foreclosure auction of Pro Farm Group, Inc. assets occurred on Januar
Slide 5: Ezequiel Simmermacher Appointed Chief Financial Officer
BIOCERES CROP SOLUTIONS Ezequiel Executive with nearly 20 years of Simmermacher experience in agribusiness and commodities across South America Appointed Former senior finance and operational executive at CHS Inc. and Monsanto Chief Financial Broad expertise across finance leadership, Officer treasu
Slide 6: Pro Farm Foreclosure Impact on Financial Statements
BIOCERES CROP SOLUTIONS Pro Farm Foreclosure Impact on Financial Statements Results of the discontinued operation are presented separately from continuing operations in financial statements Based on the expected proceeds from the foreclosure auction, we recognized an impairment loss to reflect this
Slide 7: 3Q26 Revenue by Segment
BIOCERES CROP SOLUTIONS 3Q26 Revenue by Segment 3Q26 Revenue Bridge Key Drivers ($ Million) ($ Million) Crop Protection affected by softer 3.2 51.1 demand dynamics and competitive -71% (5.5) 1.5 pressures (7.7) 39.4 Seeds performance reflects lower seed Total Revenue and grain sales during ongoing p
Slide 8: 3Q26 Gross Profit by Segment
BIOCERES CROP SOLUTIONS 3Q26 Gross Profit by Segment 3Q26 3Q26 Gross Profit Bridge Key Drivers ($ Million) Gross profit performance reflected lower 1.0 18.1 (2.4) revenues, product mix effects and -54% inoculants obsolescence adjustments (1.1) (1.9) Crop Protection margin impacted by lower Gross Pro
Slide 9: 3Q26 Adjusted EBITDA
BIOCERES CROP SOLUTIONS 3Q26 Adjusted 3Q26 EBITDA1 ($ Million) 9.1 (5.8) 1.4 (8.0) Underlying Adj. EBITDA1 performance reflected lower gross profit, partially offset by continued 2.7 operating expense reductions and improved JV results Year-over-year comparison was additionally impacted by the absen
Slide 10: Balance Sheet & Cash Position
BIOCERES CROP SOLUTIONS Balance Sheet 2Q26 ($ Million) ($ Million) 3Q26 ($ Million) & Cash Position Net Debt Net Debt 8.1x 12.7x Adj. EBITDA1 Adj. EBITDA1 216.0 214.0 Total Financial Debt remained broadly stable quarter over quarter at $228.8 194.4 174.7 million Management continued advancing liabil
Slide 11: Ongoing Strategic and Operational Initiatives
BIOCERES CROP SOLUTIONS Ongoing Strategic and Operational Initiatives Strategic review of Internal risk, governance Rizobacter debt reprofiling continuing operations and compliance processes • Assessment of portfolio composition, • External review of all internal risk, • Process under way, with sign
Slide 12: Exhibits
Exhibits
Slide 13: Unaudited Consolidated Statement of Comprehensive Income
BIOCERES CROP SOLUTIONS Three-month Three-month Unaudited Continuing operations period ended period ended 03/31/2026 03/31/2025 Revenues from contracts with customers 38.2 50.1 Consolidated Initial recognition and changes in the fair value of biological assets at the point of harvest 1.2 1.0 Cost of
Slide 14: Unaudited Consolidated Statement of Financial Position
BIOCERES CROP SOLUTIONS Unaudited ASSETS 31/03/2026 30/06/2025 LIABILITIES 31/03/2026 30/06/2025 CURRENT ASSETS CURRENT LIABILITIES Trade and other payables 79.6 96.4 Cash and cash equivalents 14.4 32.7 Consolidated Other financial assets Trade receivables 0.5 136.3 2.0 165.9 Borrowings Employee ben
Slide 15: Non-IFRS Financial Measures
BIOCERES CROP SOLUTIONS Non-IFRS Financial Measures Adjusted EBITDA The company defines adjusted EBITDA as net income/(loss) exclusive of • Other companies may calculate adjusted EBITDA and similarly titled financial income/(costs), income tax benefit/(expense), depreciation, measures differently, l
Slide 16: Contact Us: Investor Relations
Contact Us: Investor Relations Investorrelations@biocerescrops.com // Investors.biocerescrops.com
Bioceres Crop Solutions — Q3 2026 Earnings Presentation on 6ix